Physician profile
Jason E Steimel
NPI 1205397296
$2,444.53
in general payments reported to CMS, 2019-2025
10 companies · $930 in 2025
The $930 reported for 2025 was more than what 99% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $562 · 2024: $952 · 2025: $930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,444.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,708.39 | 2023-2025 | Farapulse, Watchman Flx, Rhythmia Mapping System |
| Edwards Lifesciences Corporation | $370.57 | 2023-2025 | Hemosphere, Sapien 3 Ultra Resilia |
| Biosense Webster, INC. | $142.39 | 2024-2025 | Carto 3 |
| Pacira Pharmaceuticals Incorporated | $67.10 | 2023-2025 | Iovera, Exparel |
| Mindray Ds USA, INC. | $41.80 | 2023 | A7 Anesthesia System |
| Medtronic, INC. | $38.69 | 2025 | Pipeline |
| Becton, Dickinson and Company | $24.40 | 2025 | Swan-Ganz |
| Abiomed | $21.74 | 2025 | |
| Cvrx, INC. | $15.85 | 2025 | Barostim Neo System |
| W. L. Gore & Associates, INC. | $13.60 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Steimel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.